Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002

Authors

  • Robert Menzies National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS)
  • Peter McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS)
  • Frank Beard National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS)
  • National Centre for Immunisation Research and Surveillance

DOI:

https://doi.org/10.33321/cdi.2004.28.11

Keywords:

Aboriginal, indigenous people, Torres Strait Islander, vaccination coverage, vaccine preventable disease

Abstract

This report was al also published as a separate Communicable Diseases Intelligence supplementary issue. The supplement issue includes an expanded Executive Summary.

This report complements the Vaccine Preventable Diseases and Vaccination Coverage reports produced biennially since 2000 by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases in association with the Australian Institute of Health and Welfare. It integrates the available sources of routinely collected data relevant to the current status of vaccine preventable diseases and vaccine coverage in Aboriginal and Torres Strait Islander people in Australia. It aims to better inform Indigenous communities, Indigenous health care providers and planners of immunisation services of the current status and future needs for vaccine prevention in Indigenous people. The data presented here demonstrate that vaccination programs have had a significant impact on the health of Aboriginal and Torres Strait Islander people. Several areas are highlighted for further development of vaccination policy recommendations, in particular high rates of preventable hepatitis A and B, influenza and pneumococcal disease. Areas where more research is needed include means to more accurately monitor vaccination status, the applicability of meningococcal serogroup B vaccines when available, and effective ways of increasing vaccination coverage and timeliness of vaccination. Such issues need to be considered and implemented in full cooperation with Aboriginal and Torres Strait Islander people. Commun Dis Intell 2004;28:127–159.

Downloads

Download data is not yet available.

References

Australian Bureau of Statistics, Australian Institute of Health and Welfare. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples: 2003. Canberra: Australian Bureau of Statistics; 2003.

Berkman LF, Kawachi I, editors. Social Epidemiology. New York: Oxford University Press; 2000.

Australian Bureau of Statistics, Australian Institute of Health and Welfare. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples: 2001. Canberra: Australian Bureau of Statistics; 2001.

National Health and Medical Research Council. Surveillance Case Definitions. Canberra: Australian Government Publishing Service; 1994.

Roche P, Krause V. Invasive pneumococcal disease in Australia, 2001. Commun Dis Intell 2002;26:505–519.

Australian Bureau of Statistics. Australian Demographic Statistics. Canberra: Australian Bureau of Statistics; 2003.

O'Brien ED, Sam GA, Mead C. Methodology for measuring Australia's childhood immunisation coverage. Commun Dis Intell 1998;22:36–37.

Australian Bureau of Statistics. National Health Survey, Australia, 2001: Users' Guide. Canberra: Australian Bureau of Statistics; 2003.

Australian Bureau of Statistics. Occasional Paper: Hospital Statistics, Aboriginal and Torres Strait Islander Australians, 1999–2000. Canberra: Australian Bureau of Statistics; 2002.

MacIntyre CR, Ackland MJ, Chandraraj EJ, Pilla JE. Accuracy of ICD–9–CM codes in hospital morbidity data, Victoria: implications for public health research. Aust N Z J Public Health 1997;21:477–482.

McIntyre P, Amin J, Gidding H, Hull B, Torvaldsen S, Tucker A, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1993–1998. Commun Dis Intell 2000;24 Suppl:1–83.

McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell 2002;26 Suppl:1–111.

Hull BP, McIntyre PB, Couzos S. Evaluation of immunisation coverage for Aboriginal and Torres Strait Islander children using the Australian Childhood Immunisation Register. Aust N Z J Public Health 2004;28:47–52.

Hull B, Lawrence G, MacIntyre CR, McIntyre P. Immunisation Coverage: Australia 2001. Canberra: Commonwealth Department of Health and Ageing; 2002.

Ross K. Occasional paper: Population issues, Indigenous Australian, 1996. Canberra: Australian Bureau of Statistics; 1999.

Koo W, Oley C, Munro R, Tomlinson P. Systemic Haemophilus influenzae infection in childhood. Med J Aust 1982;2:77–80.

McIntyre PB, Leeder SR, Irwig LM. Invasive Haemophilus influenzae type b disease in Sydney children 1985–1987:a population-based study. Med J Aust 1991;154:832–837.

Gilbert GL, Clements DA, Broughton SJ. Haemophilus influenzae type b infections in Victoria, Australia, 1985 to 1987. Pediatr Infect Dis J 1990;9:252–257.

McGregor AR, Bell JM, Abdool IM, Collignon PJ. Invasive Haemophilus influenzae infection in the Australian Capital Territory region. Med J Aust 1992;156:569–572.

Hanna J. The epidemiology and prevention of Haemophilus influenzae infections in Australian aboriginal children. J Paediatr Child Health 1992;28:354–361.

Horby P, Gilmour R, Wang H, McIntyre P. Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Commun Dis Intell 2003;27:324–341.

Markey P, Krause V, Boslego JW, Coplan PM, Dargan JM, Kaplan KM. The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data. Epidemiol Infect 2001;126:31–36.

Wilson N, Wenger J, Mansoor O, Baker M, Martin D. The beneficial impact of Hib vaccine on disease rates in New Zealand children. N Z Med J 2002;115:U122.

Galil K, Singleton R, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179:101–106.

Plotkin SA, Orenstein Western Australia. Vaccines. 3rd edition. Philadelphia: WB Saunders; 1999.

Chin J, editor. Control of communicable diseases manual. 17th edition. Washington DC: American Public Health Association; 2000.

Hanna JN, Warnock TH, Shepherd RW, Selvey LA. Fulminant hepatitis A in indigenous children in north Queensland. Med J Aust 2000;172:19–21.

Bowden FJ, Currie BJ, Miller NC, Locarnini SA, Krause VL. Should aboriginals in the 'top end' of the Northern Territory be vaccinated against hepatitis A? Med J Aust 1994;161:372–373.

Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1–37.

Pecoraro CA, Wasley A. Changing trends in hepatitis A in the era of childhood vaccination. Atlanta: Centers for Disease Control and Prevention; 2003.

Hanna JN, Hills SL, Humphreys JL. The impact of hepatitis A vaccination of Indigenous children on the incidence of hepatitis A in North Queensland. Communicable Diseases Control Conference; 31 March–1 April 2003; Canberra.

MacIntyre CR, Burgess MA, Hull B, McIntyre PB. Hepatitis A vaccination options for Australia. J Paediatr Child Health 2003;39:83–87.

Kaldor JM, Plant AJ, Thompson SC, Longbottom H, Rowbottom J. The incidence of hepatitis B infection in Australia: an epidemiological review. Med J Aust 1996;165:322–326.

Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: Chronic viral hepatitis. BMJ 2001;322:219–221.

Mandell GL, Bennett JE, Dolin R, editors. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th edition. Philadelphia: Churchill Livingstone; 2000.

National Health and Medical Research Council. The Australian Immunisation Handbook, 7th edition. Canberra: Australian Government Publishing Service; 1999.

Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232–239.

Recommended childhood and adolescent immunization schedule–United States, January–June 2004. MMWR Morb Mortal Wkly Rep 2004;53:Q1–Q4.

Turnbull FM, Burgess MA, McIntyre PB, Lambert SB, Gilbert GL, Gidding HF, et al. The Australian Measles Control Campaign, 1998. Bull World Health Organ 2001;79:882–888.

Hanna JN, Symons DJ, Lyon MJ. A measles outbreak in the Whitsundays, Queensland: the shape of things to come? Commun Dis Intell 2002;26:589–592.

Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell 2001;25:133–136.

Patel M, Lush D. Measles vaccine effectiveness in Central Australian aboriginal children vaccinated at or after eight months of age. Aust N Z J Public Health 1998;22:729–730.

Miller N. Changes to the Northern Territory childhood vaccination schedule—MMR. The Northern Territory Disease Control Bulletin 1998;5:1–2.

Patel MS, Merianos A, Hanna JN, Vartto K, Tait P, Morey F, et al. Epidemic meningococcal meningitis in Central Australia, 1987–1991. Med J Aust 1993;158:336–340.

Pearce MC, Sheridan JW, Jones DM, Lawrence GW, Murphy DM, Masutti B, et al. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination. Lancet 1995;346:20–23.

Downloads

Published

01/06/04

How to Cite

Menzies, Robert, Peter McIntyre, Frank Beard, and National Centre for Immunisation Research and Surveillance. 2004. “Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 1999 to 2002”. Communicable Diseases Intelligence 28 (June):127-58. https://doi.org/10.33321/cdi.2004.28.11.

Most read articles by the same author(s)

<< < 4 5 6 7 8 9